` GUBRA (Gubra A/S) vs OMX Copenhagen 25 Comparison - Alpha Spread

G
GUBRA
vs
O
OMX Copenhagen 25

Over the past 12 months, GUBRA has underperformed OMX Copenhagen 25, delivering a return of -28% compared to the OMX Copenhagen 25's 10% drop.

Stocks Performance
GUBRA vs OMX Copenhagen 25

Loading
GUBRA
OMX Copenhagen 25
Add Stock

Performance Gap
GUBRA vs OMX Copenhagen 25

Loading
GUBRA
OMX Copenhagen 25
Difference
www.alphaspread.com

Performance By Year
GUBRA vs OMX Copenhagen 25

Loading
GUBRA
OMX Copenhagen 25
Add Stock

Competitors Performance
Gubra A/S vs Peers

OMX Copenhagen 25
GUBRA
0KHE
TMO
DHR
207940
Add Stock

Gubra A/S
Glance View

Nestled in the scientific hub of Denmark, Gubra A/S has carved a niche for itself in the dynamic world of biotechnology. Since its inception in 2008, the company has anchored its reputation on its pioneering work in preclinical contract research. At its core, Gubra specializes in providing pivotal insights and support for pharmaceutical giants working on metabolic and fibrotic diseases. Through meticulous study and advanced technological frameworks, such as their proprietary imaging platforms and tailored animal models, Gubra delivers essential data that propels drug discovery forward. Their B2B model thrives on collaborating with major pharmaceutical firms, assisting them in navigating the complex maze of early-stage drug development. Beyond its contract research capabilities, Gubra has also ventured into developing its own proprietary pipeline of peptide-based drug candidates. This dual-strategy approach demonstrates their deft versatility—balancing service-based revenue streams with the potential high returns from successful drug development. While their focus remains predominantly on addressing metabolic ailments like diabetes and obesity, the company's exploration into fibrosis shows a forward-thinking attitude towards expanding their portfolio. By combining cutting-edge research with strategic alliances, Gubra continues to position itself as a vital player in biotech, capturing the synergies between scientific innovation and commercial application.

GUBRA Intrinsic Value
908.69 DKK
Undervaluation 55%
Intrinsic Value
Price
G
Back to Top